Compared to Estimates, Cognizant (CTSH) Q1 Earnings: A Look at Key Metrics

30.04.25 23:30 Uhr

Werte in diesem Artikel
Aktien

63,76 EUR 0,66 EUR 1,05%

Indizes

PKT PKT

19.571,0 PKT 26,1 PKT 0,13%

1.854,4 PKT -8,4 PKT -0,45%

5.569,1 PKT 8,2 PKT 0,15%

For the quarter ended March 2025, Cognizant (CTSH) reported revenue of $5.12 billion, up 7.5% over the same period last year. EPS came in at $1.23, compared to $1.12 in the year-ago quarter.The reported revenue represents a surprise of +0.95% over the Zacks Consensus Estimate of $5.07 billion. With the consensus EPS estimate being $1.19, the EPS surprise was +3.36%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Financial services: $1.46 billion versus the two-analyst average estimate of $1.43 billion. The reported number represents a year-over-year change of +5.6%. Revenue- Communications, Media and Technology: $804 million versus $833.33 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.7% change. Revenue- Products and Resources: $1.28 billion versus $1.27 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +12.8% change. Revenue- Health Sciences: $1.57 billion versus $1.55 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +11% change. View all Key Company Metrics for Cognizant here>>>Shares of Cognizant have returned -4.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Cognizant und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Cognizant

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cognizant

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Cognizant Corp.

Wer­bung

Analysen zu Cognizant Corp.

DatumRatingAnalyst
03.05.2019Cognizant HoldNeedham & Company, LLC
03.05.2019Cognizant PerformOppenheimer & Co. Inc.
07.02.2019Cognizant OutperformBMO Capital Markets
02.11.2018Cognizant Market PerformBMO Capital Markets
08.02.2018Cognizant OverweightBarclays Capital
DatumRatingAnalyst
07.02.2019Cognizant OutperformBMO Capital Markets
02.11.2018Cognizant Market PerformBMO Capital Markets
08.02.2018Cognizant OverweightBarclays Capital
08.02.2018Cognizant Strong BuyNeedham & Company, LLC
08.11.2017Cognizant BuyPivotal Research Group
DatumRatingAnalyst
03.05.2019Cognizant HoldNeedham & Company, LLC
03.05.2019Cognizant PerformOppenheimer & Co. Inc.
10.01.2017Cognizant Technology Solutions HoldLoop Capital
30.09.2016Cognizant Technology Solutions HoldArgus Research Company
09.09.2016Cognizant Technology Solutions NeutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
02.03.2009Cognizant Technology underperformWachovia Securities, LLC
18.12.2006Update Cognizant Technology Solutions Corp.: UnderHSBC Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognizant Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen